NR566 / NR 566 Final Exam (Latest 2026/2027): Advanced
Pharmacology for Care of the Family – Chamberlain | Verified
Questions & Answers | A+ Graded
Gradegurus
➢
➢Latest 2026/2027) Advanced Pharmacology For Care Of
➢
➢
➢
,NR 566 Final Exam - Organized Study Guide
I. FDA Regulations & Supplement Laws
1. What is the purpose of the Food, Drug, and Cosmetic Act?
Options:
Simplifies the approval process for prescription drugs.
Ensures all drugs are immediately available without approval.
Requires drugs, both prescription and OTC, go through rigorous evaluation of
safety before receiving FDA approval.
Focuses solely on the packaging and marketing of drugs.
Answer: Requires drugs, both prescription and OTC, go through rigorous
evaluation of safety before receiving FDA approval.
Explanation: The FD&C Act of 1938 established that drugs must undergo safety
testing before marketing. It was enacted after a mass poisoning event
(sulfanilamide elixir containing diethylene glycol killed over 100 people). It gave
the FDA authority to require safety data, but efficacy requirements came later with
the Kefauver-Harris Amendments of 1962.
2. What is the purpose of the Dietary Supplement Health and
Education Act of 1994?
Options:
Dietary supplements are regulated by the DEA and subject to strict controls.
Dietary supplements are food supplements and not drugs, therefore they are
exempt from the FDA approval process.
Dietary supplements must undergo rigorous FDA testing and approval.
, Dietary supplements are classified as drugs and require prescriptions.
Answer: Dietary supplements are food supplements and not drugs, therefore
they are exempt from the FDA approval process.
Explanation: DSHEA (1994) classified dietary supplements as foods, not drugs.
This means manufacturers do not need FDA approval before marketing—they are
responsible for ensuring product safety and labeling accuracy. The FDA can take
action only after a product is found to be unsafe.
3. What does the Dietary Supplement and Nonprescription Drug
Consumer Protection Act of 2006 mandate?
Options:
Requires detailed labeling of all nonprescription drugs.
Mandates approval of all nonprescription drugs by the FDA.
Reporting of serious adverse effects of nonprescription drugs and dietary
supplements.
Regulation of the pricing of nonprescription drugs and supplements.
Answer: Reporting of serious adverse effects of nonprescription drugs and
dietary supplements.
Explanation: This act established a mandatory adverse event reporting system for
dietary supplements and OTC drugs. Manufacturers must report serious adverse
events to the FDA within 15 business days.
4. What is the purpose of the Current Good Manufacturing
Practices ruling of 2007?
Options:
Controls the distribution and sales of dietary supplements.
, Oversees the pricing and taxation of supplement products.
Standardizes the marketing and advertising of supplements.
Regulates supplement manufacturing and labeling to make sure supplements
are free of contaminates and to prevent mislabeling.
Answer: Regulates supplement manufacturing and labeling to make sure
supplements are free of contaminates and to prevent mislabeling.
Explanation: cGMP regulations ensure that dietary supplements are produced
consistently, meet quality standards, and are free from contaminants. They
address manufacturing, packaging, labeling, and storage practices.
II. Antidepressants
5. When are initial and maximal results seen when a patient is
on antidepressants?
Options:
4-8 weeks.
In the case of any unknown underlying cardiac condition.
Begin days to weeks. Persist 1-3 weeks.
Initial: 1-3 weeks Maximal: 12 weeks
Answer: Initial: 1-3 weeks Maximal: 12 weeks
Explanation: Antidepressants typically show initial improvement in sleep, appetite,
and energy within 1-3 weeks, but full therapeutic effect on mood takes 6-12
weeks. Patients should be counseled to continue medication even if immediate
improvement isn't noticed.
6. What is a black box warning for all antidepressants?